#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
A tectal glioma is a low-grade, slow-growing brain tumor in the tectum, the roof of the brain stem. The brain stem controls vital body functions such as breathing, heart rate and blood pressure.
How Dana-Farber/Boston Children's approaches tectal gliomas
Children with tectal gliomas are treated at Dana-Farber/Boston Children's through our Glioma Program, one of the world's largest pediatric glioma treatment programs. Our internationally-recognized pediatric brain tumor specialists have extensive expertise in treating all types of gliomas, including tectal gliomas.
Find in-depth information on tectal glioma on the Dana-Farber/Boston Children's website, including answers to:
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”